High von Willebrand Factor Levels Increase the Risk of Stroke
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (10) , 2151-2156
Abstract
Background and Purpose— Many studies have investigated the role of plasma von Willebrand factor level in coronary heart disease, but few have investigated its role in stroke. The aim of this study was to determine if von Willebrand factor levels are associated with the risk of stroke. Methods— The study was part of the Rotterdam Study, a large population-based cohort study among subjects aged ≥55 years. We included 6 250 participants who were free from stroke at baseline (1997 to 2001) and for whom blood samples were available. Follow-up for incident stroke was complete up to January 1, 2005. Data were analyzed with Cox proportional hazards models adjusted for age and sex and additionally with models adjusted for other potential confounders including ABO blood group. A subgroup analysis was performed in participants without atrial fibrillation. Effect modification by sex was tested on a multiplicative and on an additive scale. Results— During an average follow-up time of 5.0 years, 290 first-ever strokes occurred, of which 197 were classified as ischemic. The risk of stroke increased with increasing von Willebrand factor levels (age- and sex-adjusted hazard ratios per SD increase in von Willebrand factor level: 1.12 [95% CI, 1.01 to 1.25] for stroke, 1.13 [95% CI, 0.99 to 1.29] for ischemic stroke). Adjustments for additional confounders slightly attenuated the association. The association was also present in subjects without atrial fibrillation and did not differ between sexes. Conclusion— High von Willebrand factor levels are associated with stroke risk in the general population.Keywords
This publication has 28 references indexed in Scilit:
- The Rotterdam Study: 2010 objectives and design updateEuropean Journal of Epidemiology, 2009
- Gender Differences in Acute Ischemic StrokeStroke, 2009
- Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomesThe Lancet Neurology, 2008
- Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 WomenPLOS Genetics, 2008
- ABO(H) blood groups and vascular disease: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2008
- Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and StrokeCirculation, 2007
- High von Willebrand Factor Levels Increase the Risk of First Ischemic StrokeStroke, 2006
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJournal Of Hypertension, 2003
- Sex Differences in First-Ever Acute StrokeStroke, 2003
- Sex Differences in the Clinical Presentation, Resource Use, and 3-Month Outcome of Acute Stroke in EuropeStroke, 2003